India News | DCGI Rejects Dr Reddy's Laboratories' Application Seeking Full Marketing Authorisation of Remdesivir

India News | DCGI Rejects Dr Reddy's Laboratories' Application Seeking Full Marketing Authorisation of Remdesivir

India News | DCGI Rejects Dr Reddy's Laboratories' Application Seeking Full Marketing Authorisation of RemdesivirGet latest articles and stories on India at LatestLY. India's central drug regulator has rejected Dr Reddy's Laboratories' application seeking approval for full marketing authorisation of anti-viral drug remdesivir which has so far been allowed restricted emergency use on COVID-19 patients in the country.